Excellos
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1155 Island Ave Ste 400, San Diego, Cali...Website
www.excellos.comRevenue
<$5 MillionIndustry
ZI Rank: 4
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
2
4
4
5
4
About Excellos
About Excellos: Built on the foundation of the San Diego Blood Bank, Excellos is focused on supplying cGMP cellular products and services, together with process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. Excellos is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies.Explore more
Excellos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Excellos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Excellos, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Excellos
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Excellos had a recent Job posting/layoffs
Product Launch: Get notified when Excellos launches new products
Earning: See what the market has to say on Excellos recently announced quarterly report
Check out if Excellos is spiking on competitors!
Funding: Get notified immidiatlly once Excellos has new funding data
Website visits: Recent activity has been detected on your website
Check if Excellos has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Excellos
Find more new buyers
Compare Similar Companies to Excellos
Compare insights from companies similar to Excellos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Excellos is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Excellos is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Excellos.
Excellos financials insights
Gather financial insights about Excellos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$15M
Excellos Tech Stack
A closer look at the technologies used by Excellos
Most Recent Scoops
New Hire
Executive Move
Excellos has announced that Jessica Wanamaker has joined the organization as Vice President, Business Development.
Event
Events, Medical Research, Pharmaceuticals, Clinical Operations, Healthcare Operations, Healthcare Technology
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Project
Sales
Excellos News & Media
Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area
SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO) member of Blood Centers of America (BCA), today announced that it has been selected to manufacture Galapagos’ CAR-T cell therapy candidate, GLPG5101, for its recently FDA cleared ATALANTA-1 clinical study in patients with relapsed/refractory non-Hodgkin lymphoma in the U.S. Galapagos (Euronext & Nasdaq: GLPG) is a clinical stage biotechnology company with operations in EuropeExcellos Announces Acceleration of Commercialization, New CEO
SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced it had taken additional investment to accelerate commercialization efforts. As part of the change new CEO Thomas VanCott, Ph.D., will step in to lead the company, while David Wellis, Ph.D., will transfer to Head of Strategic Partnerships. Dr. VanCott previously held the role of Chief Scientific Officer at Combined Therapeutics, Inc. and prior was Chief TechnologyExcellos Announces Strategic Partnership and Investment from Vitalant
SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced a new partnership with Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations. The strategic partnership includes an investment by Vitalant, and cell sourcing, testing and laboratory services. It also includes collaboration with the Vitalant Innovation Center, which provides scientific research and translational developmenTC BioPharm Selects Excellos as CDMO in Anticipation of Expanded US Clinical Trial Requirements
Excellos to provide scale up solution for final manufacturing in TCBP facility EDINBURGH, Scotland, Oct. 25, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Excellos
Sign Up For FreeTo access detailed company insights
About Excellos: Built on the foundation of the San Diego Blood Bank, Excellos is focused on supplying cGMP cellular products and services, together with process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. Excellos is dedicated to improving human life by providing critical products and s... Read More
